Six months effective ocular drug levels and protection against laser CNV in a cynomolgus monkey after a single ocular administration of a biodegradable microsphere delivery system releasing a highly potent anti-VEGF domain antibody based molecule.

被引：0

作者：

Catchpole, Ian R. ^{[1
,2
]}

Adamson, Peter ^{[2
]}

Wilde, Thomas ^{[3
]}

Dobrzynski, Eric ^{[3
]}

Sychertz, Caroline ^{[3
]}

Polsky, Rodd ^{[3
]}

Haworth, Richard ^{[3
]}

Tang, Chi-Man ^{[1
]}

Smal, Jos ^{[4
]}

Van der Zwan, Judith ^{[4
]}

机构：

[1] BioPharm R&D, GSK, Stevenage, Herts, England

[2] GSK Ophthalmol, GSK, Stevenage, Herts, England

[3] GSK, PTS, King Of Prussia, PA USA

[4] Octoplus NV, Leiden, Netherlands

来源：

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1498

引用

页数：3